Paper41006233
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study.
Frivold C and 28 others. Nat Commun, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Correlates of risk of respiratory syncytial virus disease: a prospective cohort study. Papers, record 41006233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41006233
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Respiratory Syncytial Virus Infections | Major topic |
| Respiratory Syncytial Virus, Human | Major topic |
| Humans | |
| Infant | |
| Prospective Studies | |
| Child, Preschool | |
| Male | |
| Child | |
| Female | |
| Antibodies, Viral | |
| Adult | |
| Adolescent | |
| Middle Aged | |
| Antibodies, Neutralizing | |
| Washington | |
| Oregon | |
| Young Adult | |
| Risk Factors | |
| Immunoglobulin G |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 75D30121C12297 | CDC HHS | United States | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38131692 | Tiny swabs: nasal swabs integrated into tube caps facilitate large-scale self-collected SARS-CoV-2 testing. | J Clin Microbiol | 2024 | https://conductscience.org/library/papers/38131692 | PubMed |
| 2 | 173995 | Respiratory syncytial virus infections within families. | N Engl J Med | 1976 | https://conductscience.org/library/papers/173995 | PubMed |
| 3 | 35598608 | Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35598608 | PubMed |
| 4 | 35235726 | Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants. | N Engl J Med | 2022 | https://conductscience.org/library/papers/35235726 | PubMed |
| 5 | 32463443 | Respiratory Syncytial Virus (RSV) Neutralizing Antibodies at Birth Predict Protection from RSV Illness in Infants in the First 3 Months of Life. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32463443 | PubMed |
| 6 | 38635270 | Respiratory Syncytial Virus Hospital-Based Burden of Disease in Children Younger Than 5 Years, 2015-2022. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/38635270 | PubMed |
| 7 | 38167333 | Incidence and transmission of respiratory syncytial virus in urban and rural South Africa, 2017-2018. | Nat Commun | 2024 | https://conductscience.org/library/papers/38167333 | PubMed |
| 8 | 33981382 | Correcting an estimator of a multivariate monotone function with isotonic regression. | Electron J Stat | 2020 | https://conductscience.org/library/papers/33981382 | PubMed |
| 9 | 19101023 | Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. | J Allergy Clin Immunol | 2009 | https://conductscience.org/library/papers/19101023 | PubMed |
| 10 | 37018468 | Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37018468 | PubMed |
| 11 | 29336703 | Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field. | Viral Immunol | 2018 | https://conductscience.org/library/papers/29336703 | PubMed |
| 12 | 38197402 | The disease burden of respiratory syncytial virus in older adults. | Curr Opin Infect Dis | 2024 | https://conductscience.org/library/papers/38197402 | PubMed |
| 13 | 7229749 | Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. | J Pediatr | 1981 | https://conductscience.org/library/papers/7229749 | PubMed |
| 14 | 34286830 | SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing. | Clin Chem | 2021 | https://conductscience.org/library/papers/34286830 | PubMed |
| 15 | 37157868 | Burden of Respiratory Viruses in Children Less Than 2 Years Old in a Community-based Longitudinal US Birth Cohort. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/37157868 | PubMed |
| 16 | 37451722 | CASCADIA: a prospective community-based study protocol for assessing SARS-CoV-2 vaccine effectiveness in children and adults using a remote nasal swab collection and web-based survey design. | BMJ Open | 2023 | https://conductscience.org/library/papers/37451722 | PubMed |
| 17 | 18929686 | Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. | J Biomed Inform | 2009 | https://conductscience.org/library/papers/18929686 | PubMed |
| 18 | 11512084 | Respiratory syncytial virus infections in previously healthy working adults. | Clin Infect Dis | 2001 | https://conductscience.org/library/papers/11512084 | PubMed |
| 19 | 38457312 | Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024. | MMWR Morb Mortal Wkly Rep | 2024 | https://conductscience.org/library/papers/38457312 | PubMed |
| 20 | 37824423 | Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023. | MMWR Morb Mortal Wkly Rep | 2023 | https://conductscience.org/library/papers/37824423 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42649230 | Mucosal IgA to pre-fusion F protein predicts protection from RSV infection in a high burden setting. | Nat Commun | 2026 | https://conductscience.org/library/papers/42649230 | PubMed |
| 42428097 | Microbial and immune determinants of disease severity and death in pediatric pneumonia. | medRxiv | 2026 | https://conductscience.org/library/papers/42428097 | PubMed |
| 42042265 | Post-Pandemic Resurgence and Seasonal Patterns of Influenza Viruses and Respiratory Syncytial Virus in Arequipa, Peru (2021-2023). | Epidemiologia (Basel) | 2026 | https://conductscience.org/library/papers/42042265 | PubMed |
| 41885612 | Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination. | J Infect Dis | 2026 | https://conductscience.org/library/papers/41885612 | PubMed |
| 41746051 | Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746051 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41006233
GET https://conductscience.org/api/papers/v1/41006233/authors?page=2